Literature DB >> 22214655

The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules.

B E Jones1, A W Basit, C Tuleu.   

Abstract

Two-piece hard shell capsules made from hypromellose (or hydroxypropyl methylcellulose, HPMC) containing carrageenan as a gelling agent have been proposed as an alternative to conventional gelatin capsules for oral drug delivery. We have previously compared the disintegration of hypromellose(carrageenan) (Quali-V(®)) and gelatin capsules (Qualicaps) in fasted human subjects using the technique of gamma scintigraphy. This second study used the same technique with both fasted and fed human subjects. Size 0 capsules were filled with powder plugs made from lactose and did not contain croscarmellose as in the original study. The capsules were separately radiolabelled with indium-111 and technetium-99m. Both capsules were administered simultaneously with 180ml water to eight healthy male subjects following an overnight fast. Each volunteer was positioned in front of the gamma camera and sequential 60s images were acquired in a continuous manner for 30min. The mean (±S.D.) disintegration time in the fasted state for the hypromellose(carrageenan) capsules was 8±2min and for gelatin 7±3min. These results were not statistically different from the data in the original study and show that the removal of the croscarmellose had no effect on the results. The mean (±S.D.) disintegration time in the fed state for the hypromellose(carrageenan) capsules was 16±5min and for the gelatin capsules was 12±4min. There was no statistical difference between the hypromellose(carrageenan) and gelatin capsules in either the fed or fasted state.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22214655     DOI: 10.1016/j.ijpharm.2011.12.034

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Development of a solid dosage platform for the oral delivery of bilayer vesicles.

Authors:  Jitinder S Wilkhu; Sarah E McNeil; David E Anderson; Marc Kirchmeier; Yvonne Perrie
Journal:  Eur J Pharm Sci       Date:  2017-06-12       Impact factor: 4.384

2.  Comparison of In Vitro and In Vivo Results Using the GastroDuo and the Salivary Tracer Technique: Immediate Release Dosage Forms under Fasting Conditions.

Authors:  Maximilian Sager; Philipp Schick; Magdalena Mischek; Christian Schulze; Mahmoud Hasan; Marie-Luise Kromrey; Hassan Benameur; Martin Wendler; Mladen Vassilev Tzvetkov; Werner Weitschies; Mirko Koziolek
Journal:  Pharmaceutics       Date:  2019-12-07       Impact factor: 6.321

3.  The effectiveness of plant hydrocolloids at maintaining the quality characteristics of the encapsulated form of L-phenylalanine-ammonia-lyase.

Authors:  Olga Babich; Lyubov Dyshlyuk; Svetlana Noskova; Alexander Prosekov; Svetlana Ivanova; Valery Pavsky
Journal:  Heliyon       Date:  2019-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.